New issue of Cambridge Quarterly of Healthcare Ethics is now available

April 19, 2011

New Issue of Cambridge Quarterly of Healthcare Ethics, (Volume 20, Issue 2) is now available.
Articles include:

  • “On Method and Resolution in Philosophical Bioethics” by John Coggon, 159-163.
  • “Classification and Normativity: Some Thoughts on Different Ways of Carving Up the Field of Bioethics” by Sørem Holm, 165 – 173.
  • “Vorsprung durch Technik: On Biotechnology, Bioethics, and Its Beneficiaries” by Nicky Priaulx, 174 – 184.
  • “Bays, Beaches, and Bioethical Barkings” by Jan Helge Solbakk, 185 – 190.
  • “Eugenics and the Genetic Challenge, Again: All Dressed Up and Just Everywhere to Go” by Tom Koch, 191-203.
  • “The Challenge of Nonconfrontational Ethics” by John Harris, 204-215.
  • “Confronting Rationality” by Ronald M. Green,216 – 227.
  • “Nonconfrontational Rationality or Critical Reasoning” by Vilhjálmur Árnason, 228-237.
  • “Are All Rational Moralities Equivalent?” by Darryn Gunson, 238-247.
  • “Genetic Enhancement in Sports: The Role of Reason and Private Rationalities in the Public Arena” by Silvia Camporesi and Paolo Maugeri, 248-257.
  • “Reasons, Rationalities, and Procreative Beneficence: Need Häyry Stand Politely By While Savulescu and Herissone-Kelly Disagree?” by Peter Herissone-Kelly, 258-267.
  • “Balancing Procreative Autonomy and Parental Responsibility” by Tom Buller and Stephanie Bauer, 268-276.
  • “Introduction: Access to Life-Saving Medicines and Intellectual Property Rights” by Doris Schroeder, 277-278.
  • “Access to Life-Saving Medicines and Intellectual Property Rights: An Ethical Assessment” by Doris Schroeder and Peter Singer, 279-289.
  • “Developing Medicines in Line with Global Public Health Needs: The Role of the World Health Organization” by Tikki Pang, 290-297.
  • “Does the Pharmaceutical Sector Have a Coresponsibility for the Human Right to Health?” by Doris Schroeder, 298-308.
  • “Access to Healthcare and the Pharmaceutical Sector” By Klause M. Leisinger and Karin M. Schmitt, 309-325.
  • “Collaborating with the Pharmaceutical Industry: An Aboriginal Perspective” by Jack Beetson, 326-328.
  • “Epilogue: New Drugs for Neglected Diseases” by Thomas Pogge and Aidan Hollis, 329-334.

Posted by

Posted in Biotech, Emerging Technologies, General Bioethics, Global Bioethics, Healthcare, Public Health, Research Ethics, Women's Health

Ad